MEDIROM Healthcare Technologies
MRM
3 hedge funds and large institutions have $66K invested in MEDIROM Healthcare Technologies in 2025 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, reducing their positions, and 3 closing their positions.
0.73% more ownership
Funds ownership: 1.55% → 2.28% (+0.73%)
40% less funds holding
Funds holding: 5 → 3 (-2)
48% less capital invested
Capital invested by funds: $127K → $66K (-$60.8K)
67% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$53.2K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$41.9K |
| 3 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$401 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HCM
Heights Capital Management
San Francisco,
California
|
-$37.4K |
| 2 |
WAM
Warberg Asset Management
Winnetka,
Illinois
|
-$23.6K |
| 3 |
GI
GAMMA Investing
Foster City,
California
|
-$5.07K |
MRM Hedge Fund Activity: Q1 2025 in Review
3 of the 7,458 institutional investors tracked by Wall St. Rank reported a position in MEDIROM Healthcare Technologies (MRM) for Q1 2025, worth a combined $66K — down 48% from $127K a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of MRM and 1 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 2 added.
The largest buyer was Citadel Advisors, opening a new position worth an estimated $53.2K. The largest seller was Heights Capital Management, exiting entirely with an estimated $37.4K sold.
- 3 institutional investors held MEDIROM Healthcare Technologies (MRM) as of Q1 2025, down from 5 in Q4 2024.
- Funds reported $66K of MEDIROM Healthcare Technologies stock for Q1 2025, down 48% quarter-over-quarter.
- 1 fund opened new MEDIROM Healthcare Technologies positions in Q1 2025 and 3 closed out, a net change of -2 holders.
- The largest MEDIROM Healthcare Technologies buyer in Q1 2025 was Citadel Advisors, an estimated $53.2K added.
- The largest MEDIROM Healthcare Technologies seller in Q1 2025 was Heights Capital Management, an estimated $37.4K sold.
Based on aggregated 13F filings for Q1 2025.